Compare KRMD & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRMD | INFU |
|---|---|---|
| Founded | 1980 | 2005 |
| Country | United States | United States |
| Employees | N/A | 473 |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.3M | 196.1M |
| IPO Year | 2019 | 2005 |
| Metric | KRMD | INFU |
|---|---|---|
| Price | $4.22 | $9.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $6.50 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 137.3K | 110.3K |
| Earning Date | 03-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 53.85 | ★ 181.82 |
| EPS | N/A | ★ 0.31 |
| Revenue | $41,127,366.00 | ★ $143,436,000.00 |
| Revenue This Year | $20.32 | $2.89 |
| Revenue Next Year | $17.38 | $7.66 |
| P/E Ratio | ★ N/A | $31.29 |
| Revenue Growth | ★ 22.23 | 6.36 |
| 52 Week Low | $1.87 | $4.61 |
| 52 Week High | $6.61 | $11.04 |
| Indicator | KRMD | INFU |
|---|---|---|
| Relative Strength Index (RSI) | 36.30 | 54.53 |
| Support Level | $4.08 | $8.52 |
| Resistance Level | $4.34 | $9.83 |
| Average True Range (ATR) | 0.20 | 0.36 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 23.36 | 60.22 |
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.